Graph theory and network topological metrics may be the potential biomarker in Parkinson's disease

被引:29
|
作者
Huang, Li-Chuan [1 ]
Wu, Ping-An [1 ]
Lin, Shinn-Zong [2 ]
Pang, Cheng-Yoong [3 ,4 ]
Chen, Shin-Yuan [2 ]
机构
[1] Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Med Imaging, Hualien, Taiwan
[2] Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Neurosurg, Hualien, Taiwan
[3] Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Med Res, Hualien, Taiwan
[4] Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Cardiovasc & Metab Res Ctr, Hualien, Taiwan
关键词
Parkinson's disease (PD); Resting-state functional magnetic resonance imaging (rs-fMRI); Functional connectivity (FC); Voxel-based morphometry (VBM); Graph theory; MILD COGNITIVE IMPAIRMENT; FUNCTIONAL CONNECTIVITY; BRAIN NETWORKS; MATTER ATROPHY;
D O I
10.1016/j.jocn.2019.07.082
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study used Voxel-based morphometry (VBM) and resting-state functional magnetic resonance imaging (rs-fMRI) to investigate changes in brain structure and networks functional connectivity, respectively. We tried to identify the potential biomarkers in Parkinson's disease (PD) progression. We recruited nine idiopathic PD patients and seven healthy control participants (HC group) who were age-matched to undergo T1-weighted images and rs-fMRI on 1.5 T. Brain structure differences were analyzed by VBM. Topological properties of networks functional connectivity were analyzed by graph theory. Thirty-two nodes of 8 networks and 133 nodes of interest then were identified with graph theory approaches. VBM examinations showed significant decreases of brain gray matter regions including the left temporal lobe, left middle temporal, middle temporal gyrus, parietal lobe, postcentral gyrus, left inferior parietal gyrus, medial frontal gyrus and supplement motor area in PD patients compared to the HC group. The 32 ROI of networks topological metrics measurement in PD demonstrated increases of global efficiency, cost, and degree in frontoparietal PPC (R) network, but decreases of local efficiency, clustering coefficient, and average path length in salience ACC, dorsal attention FEF (L), and salience alnsula (R) networks, respectively. All 165 ROI connectomes showed eight connections intensity changes, that decrease in OP r to frontoparietal PPC, putamen r to cereb11, and SFG I to Ver8 in PD. These results suggest that the graph theory and the network topological metrics measurement may be the potential biomarkers in PD to evaluate the disease progress and to monitor the therapeutic results. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码:235 / 242
页数:8
相关论文
共 50 条
  • [31] Complexity of electrocortical activity as potential biomarker in untreated Parkinson’s disease
    Giovanni Mostile
    Loretta Giuliano
    Valeria Dibilio
    Antonina Luca
    Calogero Edoardo Cicero
    Vito Sofia
    Alessandra Nicoletti
    Mario Zappia
    Journal of Neural Transmission, 2019, 126 : 167 - 172
  • [32] Olfactory function and apathy as potential biomarker in patients with Parkinson's disease
    Masala, Carla
    Piras, Raffaella
    Solla, Paolo
    Liscia, Anna
    Loy, Francesco
    Defazio, Giovanni
    Saba, Luca
    Cannas, Antonino
    Cavazzana, Annachiara
    Hummel, Thomas
    Haehner, Antje
    CHEMICAL SENSES, 2019, 44 (03) : E60 - E60
  • [33] Ecto-GPR37: a potential biomarker for Parkinson’s disease
    Xavier Morató
    Paula Garcia-Esparcia
    Josep Argerich
    Franc Llorens
    Inga Zerr
    Wojciech Paslawski
    Eva Borràs
    Eduard Sabidó
    Ulla E. Petäjä-Repo
    Víctor Fernández-Dueñas
    Isidro Ferrer
    Per Svenningsson
    Francisco Ciruela
    Translational Neurodegeneration, 10
  • [34] Aggregated α-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson's Disease
    Dimoula, Konstantina
    Papagiannakis, Nikolaos
    Maniati, Matina
    Stefanis, Leonidas
    Emmanouilidou, Evangelia
    PARKINSONISM & RELATED DISORDERS, 2025, 133
  • [35] miR-124 and Parkinson's disease: A biomarker with therapeutic potential
    Angelopoulou, Efthalia
    Paudel, Yam Nath
    Piperi, Christina
    PHARMACOLOGICAL RESEARCH, 2019, 150
  • [36] Analysis of total RNA as a potential biomarker of Parkinson's disease in silico
    Jovicic, Snezana M.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2025, 39
  • [37] α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease
    Cao, Zhentang
    Wu, Yufeng
    Liu, Genliang
    Jiang, Ying
    Wang, Xuemei
    Wang, Zhan
    Feng, Tao
    NEUROSCIENCE LETTERS, 2019, 696 : 114 - 120
  • [38] Low serum uric acid levels may be a potential biomarker of poor sleep quality in patients with Parkinson's disease
    Zhou, Chuanbin
    Gu, Meijuan
    Yin, Lei
    Yin, Weifang
    Liu, Jie
    Zhu, Yongyun
    Yin, Kangfu
    Lei, Chunyan
    Xu, Zhong
    Yang, Xinglong
    SLEEP MEDICINE, 2023, 105 : 9 - 13
  • [39] Deep cervical lymph nodes in Parkinson's disease and atypical Parkinson's disease: A potential ultrasound biomarker for differential diagnosis
    Dong, Zhaoying
    Du, Xinyi
    Wang, Ling
    Zou, Xiaoya
    Zuo, Hongzhou
    Yan, Yong
    Chen, Guojun
    Cheng, Oumei
    Zhang, Yong
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2024, 16
  • [40] An auditory biomarker for Parkinson's disease?
    De Keyser, K.
    Bockstael, A.
    Botteldooren, D.
    Talsma, D.
    De Letter, M.
    Santens, P.
    MOVEMENT DISORDERS, 2017, 32